JAK2 and renal cell carcinoma: MicroRNA-363 could inhibit the JAK2-STAT3 axis though specifically binding to GHR and downregulating the expression of GHR, leading to the inhibition of the angiogenesis, proliferation, invasion, and migration in RCC [120].